CEO of $XMTR Sells 27 Shares in Insider Sale

Randolph Altschuler, the CEO of $XMTR, recently disposed of 27 company shares worth approximately $1,416, according to a SEC filing. This transaction represented around 0.0% of his current holdings, which now total 310,271 shares in this particular class of stock.

Over the last six months, $XMTR insiders have actively engaged in stock trading, with a total of 24 transactions recorded. Notably, all of these transactions were sales, with no purchases made. The breakdown of insider trading activities by key executives is as follows: the Chief Executive Officer, Randolph Altschuler, has executed 6 sales transactions, selling 18,663 shares valued at $771,626. The Chief Operating Officer, Peter Goguen, undertook 3 sales transactions, divesting 11,486 shares for an estimated $422,719. Emily Rollins, another key insider, sold 12,041 shares in 5 transactions, amounting to $349,596. James Miln, the Chief Financial Officer, made 7 sales transactions selling 2,318 shares for $117,603. Lastly, the Chief Technology Officer, Vaidyanathan Raghavan, executed 3 sales transactions selling 1,298 shares for $65,282.

Moreover, institutional investors have also been actively involved in trading $XMTR stock in the most recent quarter. Notably, 107 institutional investors increased their holdings, while 85 reduced their positions. Some notable moves by institutional investors include Summit Partners Public Asset Management, LLC adding 858,579 shares in Q2 2025, valued at $29,011,384. FMR LLC acquired 659,097 shares during the same period, totaling $22,270,887. Gilder Gagnon Howe & Co LLC added 613,282 shares, amounting to $20,722,798. Baillie Gifford & Co augmented their holdings by 78.0% with the addition of 568,032 shares valued at $19,193,801. On the other hand, Owls Nest Partners IA, LLC divested all of their 520,382 shares in Q2 2025, totaling $17,583,707. Stephens Investment Management Group LLC added 393,360 shares, while First Trust Advisors LP acquired 384,211 shares during the same period, adding $13,291,634 and $12,982,489 to their respective portfolios.

Financial analysts have closely monitored $XMTR in recent months, with a total of 4 firms issuing buy ratings and 1 firm issuing a sell rating. JMP Securities rated the stock as “Market Outperform” on 08/06/2025, while Goldman Sachs marked it as “Buy” on the same day. JP Morgan issued an “Overweight” rating on 06/03/2025, while Cantor Fitzgerald labeled it as “Underweight” on 05/07/2025. Citizens Capital Markets also issued a “Market Outperform” rating on 04/22/2025.

Lastly, numerous analysts have provided price targets for $XMTR in the past 6 months, with a median target of $40.0. Notably, analysts such as Andrew Boone from JMP Securities, Karl Keirstead from UBS, and Bruno Montanari from Goldman Sachs have set target prices of $50.0, $40.0, and $42.0, respectively. Other analysts from reputable firms have also issued their price targets, providing investors with a range of estimates to consider.